Zwickau, Germany

Tobias Poehlmann

This inventor holds 4 USPTO granted patents and 4 published patent applications, plus 1 CIPO patent. Top assignees: Friedrich-Schiller-Universitaet Jena, Universitaetsklinikum Jena. Active years: 2016-2025.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Tobias Poehlmann. Retrieved from https://idiyas.com/inventor/tobias-poehlmann

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 4 

% Patents Active = 100.0


Average Co-Inventor Count = 2.5

ph-index = 1


Location History:

  • Zwickau, DE (2016)
  • Jena, DE (2016)

Company Filing History:


Years Active: 2016-2025

Loading Chart...
Loading Chart...
4 patents (USPTO):Explore Patents

Title: **The Innovative Mind of Tobias Poehlmann**

Introduction

Tobias Poehlmann, an accomplished inventor based in Zwickau, Germany, has made significant strides in the field of biotechnology. With a total of three patents to his name, his inventions focus on the development of biologically active molecules aimed at combating various medical challenges, particularly those related to infections and tumors.

Latest Patents

Among Tobias’s most notable patents is the invention of biologically active molecules designed for the targeted inhibition of virus-, bacteria-, and parasite-infected cells, as well as tumor cells. This innovative approach allows for effective treatment, even in cases where mutations have occurred. The invention utilizes biologically active molecules that include protease inhibitors specific to relevant target proteases found within afflicted cells. This patent outlines a method for delivering peptide-inhibited siRNA, PNA, or RNA, enabling the activation of these agents to influence gene expression in diseased or infected cells. Another significant patent involves the selective activation of biologically active molecules by covalently bonding them to peptides tailored to be recognized by specific enzymes within target cells. This ensures that the molecules remain inactive until they reach their intended destination, providing a cutting-edge solution for addressing gene expression in sick or infected cells.

Career Highlights

Throughout his career, Tobias Poehlmann has been affiliated with esteemed institutions. Notably, he has worked at Friedrich Schiller University Jena and the Jena University Hospital, where he contributed to advanced research in the field of biotechnology. His involvement in these institutions has allowed him to be at the forefront of significant medical research and innovation.

Collaborations

Tobias has collaborated with accomplished colleagues such as Rolf Guenther and Lydia Seyfarth. These collaborations have not only enhanced his research but have also facilitated the sharing of ideas and technologies, leading to further advancements in the field.

Conclusion

In conclusion, Tobias Poehlmann is a visionary inventor whose contributions to biotechnology hold great promise for the future of medical treatments. His innovative patents targeting infectious and tumor cells demonstrate not only his expertise but also his commitment to improving health outcomes. With a strong background in research and valuable collaborations, Tobias continues to pave the way for future innovations in this critical field.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…